COMMUNIQUÉS West-GlobeNewswire

Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025

14/03/2025 - 12:00

SAN DIEGO, March 14, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health [...]

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

14/03/2025 - 11:50

- Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence study - - Company expects to submit New Drug Application (NDA) in April 2025 - DEER PARK, Ill., March 14, 2025 (GLOBE NEWSWIRE [...]

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

14/03/2025 - 11:50

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME) ANI plans to begin marketing ILUVIEN in the U.S. [...]

Coloplast Finance B.V. - Decisions at the Annual General Meeting

14/03/2025 - 11:25

On 14 March 2025, Coloplast Finance B.V. held its Annual General Meeting. At the Annual General Meeting, the sole shareholder, Coloplast A/S, approved the annual report for the financial year 2023/24. In addition, Ernst [...]

Avextra Showcases Study Findings on World Sleep Day 2025

14/03/2025 - 10:52

Cannabis-Based Therapy Shows Promise in Improving Sleep Quality and Pain Management Bensheim, Germany – 14 March 2025 – In anticipation of World Sleep Day, Avextra has revealed findings from its IMPACT study at the [...]

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea

14/03/2025 - 07:15

Allschwil, Switzerland, March 14, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal [...]

Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturia

14/03/2025 - 07:00

Daridorexant, Idorsia’s dual orexin receptor antagonist, shows consistent efficacy across both insomnia- and nocturia-related endpoints in a placebo-controlled study in patients with chronic insomnia and nocturia In [...]

Guthrie Launches Maternity Oasis Mobile (MOM) Unit

14/03/2025 - 03:37

Please note a correction in the earlier news release. We do not provide contraception on the Maternity Oasis Mobile Unit. If you have indicated this in any of your coverage, we kindly ask that you remove it. BINGHAMTON [...]

Pineapple Inc. Provides Shareholder Update and 2025 Outlook

14/03/2025 - 01:00

Company Expands into Cannabis Business Management and Functional Mushroom Markets to Drive Growth and Profitability LOS ANGELES, CA, March 13, 2025 (GLOBE NEWSWIRE) -- Pineapple, Inc. (OTC: PNPL) (“Pineapple” or the “ [...]

Ryoncil® Product Information Now Available in All Four Major Drug Pricing Compendia in United States

14/03/2025 - 00:42

NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that pricing information for Ryoncil ® is [...]

Cellectis publie ses résultats financiers du quatrième trimestre 2024 et de l’exercice 2024 et une mise à jour de ses activités

13/03/2025 - 23:46

○ UCART22 : présentation des données de Phase 1 et de la stratégie de développement prévues au troisième trimestre 2025. Statuts de médicament orphelin et de médicament pour une maladie pédiatrique rare accordés par la [...]

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update

13/03/2025 - 23:07

○ UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) granted by FDA and ODD granted by the [...]

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2024

13/03/2025 - 22:30

MISSISSAUGA, Ontario, March 13, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2024. Key [...]

Voting Rights and Shares Capital of the Company

13/03/2025 - 22:15

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, March 13, 2025 (GLOBE NEWSWIRE [...]

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

13/03/2025 - 22:15

Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 13 mars 2025 (GLOBE NEWSWIRE) -- Paris, France, le 13 mars 2025 Place de cotation : [...]

Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

13/03/2025 - 22:00

MOUNTAIN VIEW, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of [...]

Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

13/03/2025 - 22:00

PRINCETON, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Mojdeh Poul, chief executive officer and [...]

MEDIROM Mother Labs Executive Makes Additional Investment in Mother Labs’ Series A Financing at a Pre-Money Valuation of JPY9 Billion (as of March 13, 2025, Approximately US$60 Million)

13/03/2025 - 22:00

TOKYO, March 13, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (the “Company” or “MEDIROM”) announces that Yasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs Inc. (“Mother Labs [...]

NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025

13/03/2025 - 21:30

SARASOTA, Fla. and MIAMI, March 13, 2025 (GLOBE NEWSWIRE) -- NAYA Biosciences, Inc. (“NAYA”) (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, [...]